Trinidad and Tobago vs Zambia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Trinidad and Tobago
91.0%
in 2024
Zambia
91.0%
in 2024
Trinidad and Tobago rank
52nd
Zambia rank
52nd
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Trinidad and Tobago
- Zambia
How they compare
Trinidad and Tobago currently reports 91.0% against 91.0% in Zambia, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2014 it was Trinidad and Tobago ahead.
Trinidad and Tobago ranks 52nd and Zambia ranks 52nd of 146 countries.
Trinidad and Tobago has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Trinidad and Tobago | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.8% | 87.5% | 6.3% | Trinidad and Tobago |
| 2020s | 93.6% | 87.8% | 5.8% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Trinidad and Tobago or Zambia?
- Trinidad and Tobago, at 91.0% against 91.0% in Zambia as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Trinidad and Tobago and Zambia?
- 0.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Trinidad and Tobago and Zambia?
- 11 years are reported by both, from 2014 to 2024.
- How do Trinidad and Tobago and Zambia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Trinidad and Tobago ranks 52nd and Zambia ranks 52nd of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.